SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-007929
Filing Date
2021-04-05
Accepted
2021-04-05 07:45:24
Documents
12
Period of Report
2021-04-05
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 32902
  Complete submission text file 0001493152-21-007929.txt   208925

Data Files

Seq Description Document Type Size
2 hrow-20210405.xsd EX-101.SCH 2760
3 hrow-20210405_lab.xml EX-101.LAB 35274
4 hrow-20210405_pre.xml EX-101.PRE 23149
5 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3776
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21803738
SIC: 2834 Pharmaceutical Preparations